The WHO Classification of Tumors of the Nervous System

Kleihues P Cavenee WK eds. World Health Organisation classification of tumours: Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000

Zülch KJ ed. Histologic typing of tumours of the central nervous system. Geneva, Switzerland: World Health Organization, 1979

Kleihues P Burger PC Scheithauer BW eds. Histological typing of tumours of the central nervous system. World Health Organization international histological classification of tumours, 2nd Ed. Berlin, Heidelberg: Springer Verlag, 1993

10.1111/j.1750-3639.1993.tb00752.x

Hamilton SR Aaltonen LA eds. World Health Organisation classification of tumours: Pathology and genetics of tumours of the digestive system. Lyon, France: IARC Press, 2000

Jaffe ES Harris NL Stein H Vardiman JW eds. World Health Organisation classification of tumours: Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2001

Louis DN Posner JB Jacobs T Kaplan R . Report of the brain tumor progress review group. 2000. http://osp.nci.nih.gov/prg_assess/prg/btprg

Davis FG Preston-Martin S . Epidemiology. Incidence and survival. In: Bigner DD McLendon RE Bruner JM , eds. Russell and Rubinstein's pathology of tumors of the nervous system. Sixth Ed. London: Arnold, 1998:5–45

International classification of diseases for oncology Third Edition . Fritz A, Percy C, Jack A et al, eds. Geneva, Switzerland: World Health Organization, 2000

Daumas-Duport, 1988, Grading of astrocytomas, A simple and reproducible method. Cancer, 62, 2152

10.1111/j.1750-3639.1993.tb00721.x

10.3171/jns.1994.81.3.0427

10.1111/j.1750-3639.1996.tb00848.x

10.1177/019262330002800121

10.1093/neuonc/1.1.44

Louis, 2001, Glioma classification: A molecular reappraisal, Am J Pathol, 59, 779, 10.1016/S0002-9440(10)61750-6

10.1097/00005072-199901000-00006

10.1001/archneur.56.4.434

10.1093/jnci/90.19.1473

Smith, 2000, Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas, J Clin Oncol, 18, 636, 10.1200/JCO.2000.18.3.636

10.1073/pnas.181340798

Reifenberger, 1994, Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p, Am J Pathol, 145, 1175

10.1097/00005072-199710000-00003

10.3171/jns.2000.92.6.0983

Nelson, 1996, Glioblastoma with oligodendroglial features (GBM-OL): Report from Radiation Therapy Oncology Group (RTOG) trial 8302, Lab Invest, 74, 141A

Kraus, 2001, Molecular genetic alterations in glioblastomas with oligodendroglial component, Acta Neuropathol (Berl), 101, 311, 10.1007/s004010000258

10.3109/01913129709021312

10.1002/path.1700440311

10.1097/00005072-197803000-00001

Burger PC Scheithauer BW Vogel FS . Surgical pathology of the nervous system and its coverings, 3rd Ed. London: Churchill Livingstone, 1991

10.1055/s-2008-1053399

10.1007/PL00007443

Corvi, 1995, Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells, Cancer Res, 55, 3471

10.1097/00005072-199803000-00009

10.1111/j.1750-3639.1999.tb00543.x

10.1097/00000478-200007000-00001

Taratuto AL Monges J Lylyk P Leiguarda R . Meningocerebral astrocytoma attached to dura with “desmoplastic” reaction. Proceedings of the IX International Congress of Neuropathology (Vienna), 1982

VandenBerg, 1987, Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (“desmoplastic infantile gangliogliomas”), Report on 11 cases of a distinctive embryonal tumor with favorable prognosis. J Neurosurg, 66, 58

10.1007/BF00690447

10.1016/0046-8177(94)90309-3

10.1097/00000478-199604000-00003

10.1097/00000478-199606000-00002

10.1097/00005072-198301000-00001

10.1111/j.1750-3639.1997.tb01063.x

Raffel, 1997, Sporadic medulloblastomas contain PTCH mutations, Cancer Res, 57, 842

10.1016/S0896-6273(00)80682-0

10.1101/gad.14.8.994

10.1016/S0002-9440(10)64747-5

10.1002/1098-2264(2000)9999:9999<::AID-GCC1052>3.0.CO;2-S

10.1002/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G

10.1007/s003810050547

10.1097/00000478-199207000-00007

10.1159/000028932

10.3171/jns.1996.85.1.0056

Biegel, 1999, Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors, Cancer Res, 59, 74

Biegel, 2001, Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system, Clin Cancer Res, 6, 2759

Perry, 1999, “Malignancy” in meningiomas: A clinicopathologic study of 116 patients, with grading implications, Cancer, 85, 2046

10.1097/00000478-199712000-00008

10.1227/00006123-199207000-00002

10.3171/jns.1992.77.4.0616

Rempel, 1993, Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression, Cancer Res, 53, 2386

Simon, 1995, Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression, Cancer Res, 55, 4696

10.1073/pnas.94.26.14719

Emory, 1995, Intraneural perineurioma, A clonal neoplasm associated with abnormalities of chromosome 22. Am J Clin Pathol, 103, 696

10.1097/00005537-199603000-00016

10.1002/1097-0142(197805)41:5<1823::AID-CNCR2820410525>3.0.CO;2-J

10.1002/1097-0142(19920615)69:12<2917::AID-CNCR2820691209>3.0.CO;2-8

Val-Bernal, 1997, Renal perineurioma in childhood, Gen Diagn Pathol, 143, 75

Giannini, 1997, Soft-tissue perineurioma, Evidence for an abnormality of chromosome 22, criteria for diagnosis, and review of the literature. Am J Surg Pathol, 21, 164

10.1097/00000478-199712000-00005

10.1097/00000478-199810000-00002

10.1097/00000478-199905000-00002

10.1007/s004010100445

10.1097/00000478-200106000-00008

10.3171/jns.1999.91.6.0971